13.56% institutional ownership 5.56 million shares (13.23% of the float) currently shorted Current borrow fee: 10.9 % Shares available to borrow: 35'000
A very high 61.50% of the daily volume has been shorted on Friday (as reported by FINRA) but despite the heavy efforts of the shorts, the PPS did not go down! The number of available shares for shorting is 35'000 and the borrow fee is 10.9%! The data has been published on ClinicalTrials and confirms that Multikine is a drug with a median extended life expectancy of almost 4 years and zero toxicity! Further, 5 patients had their tumours completely disappear and were CURED after 3 weeks of Multikine treatment and before surgery!! GLTAL! Tick tock, tick tock ...
Market Data 
Markets 
AI
